We’re now part of the PerkinElmer family
In 2020, PerkinElmer, Inc. (NYSE: PKI) a global leader committed to innovating for a healthier world, acquired Horizon Discovery. The acquisition has combined life science research and applied genomics portfolios to deliver an innovative suite of solutions that support scientists on their journey through drug discovery and development. Horizon’s services and reagents, which leverage gene-editing and modulation technologies, are now complemented by PerkinElmer’s imaging, detection, automation and LabChip® platforms to better enable critical elements of the drug development and therapeutic value chain, particularly in the area of precision medicine.
Horizon Discovery’s career opportunities are now accessed through the PerkinElmer career site.